Biotechnology Analyst Karnauskas discusses data to be presented at the upcoming ACC Annual Meeting 2023 for Merck’s Sotatercept for treatment of Pulmonary Arterial Hypertension (PAH) on an Analyst/Industry conference call to be held on February 15 at 1 pm. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MRK:
- Merck price target raised to $125 from $120 at Credit Suisse
- Truist biotechnology analyst to hold an analyst/industry conference call
- Aligos announces portfolio reprioritization of NASH, extends cash runway
- Merck price target raised to $118 from $106 at Truist
- Merck says Phase 3 NRG-GY018 trial met primary endpoint of PFS